+44-3308187254
+44-3308187254Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Clinical Pharmacology & Biopharmaceutics received 790 citations as per Google Scholar report
LCZ696 (sacubitril/valsartan) is a first-in-class angiotensin receptor neprilysin inhibitor that simultaneously inhibits neprilysin and blocks the angiotensin II receptor. LCZ696 has been recently approved for treatment of HF and likely be co-administered with digoxin or warfarin. The drug interaction potential between LCZ696 and digoxin or warfari... Read More»
Surya Ayalasomayajula, Pierre Jordaan, Parasar Pal, Priyamvada Chandra, Diego Albrecht, Thomas Langenickel, Iris Rajman and Gangadhar Sunkara
Research Article: Clin Pharmacol Biopharm 2015, 4:147
DOI: 10.4172/2167-065X.1000147
Abstract Peer-reviewed Full Article Peer-reviewed Article PDF
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 